Riskpilot← Back to searchSign inGet full accessALMELAND HELSE AS
ASActiveOrg 925992879Hardangerfjordvegen 615, 5610 ØysteseDental practice care activities · NACE 8623Est. 20205 employees
Revenue 2024
NOK 3,4M
+16% vs 2023
EBITDA margin
9.6%
+84% vs 2023
Equity ratio
8.3%
Financial strength
Net profit 2024
NOK 124K
+2951% vs 2023
| Revenue | NOK 3,4M | +16% |
| EBITDA | NOK 328K | +84% |
| Net profit | NOK 124K | +2951% |
| Total assets | NOK 1,6M | +1% |
| Equity | NOK 131K | +427% |
| Employees | 5 | — |
Legal name
ALMELAND HELSE AS
Org number
925992879
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
19. november 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drive verksemd som ytar av helsetenester innan tannhelse, medisin og kirurgi, drive undervising og opplæring innan helse og medisin, samt alt som høyrer naturleg til dette.
Address
Hardangerfjordvegen 615, 5610 Øystese
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 692 | 2 693 | 2 964 | 3 427 |
| Staff expenses | −0 | −1 270 | −1 400 | −1 479 | −1 673 |
| EBITDA | −24 | 152 | 346 | 178 | 328 |
| Depreciation & amort. | −0 | −209 | −126 | −132 | −132 |
| EBIT | −24 | −57 | 220 | 45 | 195 |
| Net financials | 0 | −43 | −40 | −41 | −35 |
| Profit before tax | −24 | −100 | 180 | 4 | 161 |
| Tax | −0 | −22 | 43 | 0 | 36 |
| Net profit | −24 | −78 | 137 | 4 | 124 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 | 1 797 | 1 886 | 1 575 | 1 584 |
| Equity | 6 | −64 | 21 | 25 | 131 |
| Long-term debt | 0 | 1 009 | 880 | 724 | 570 |
| Short-term debt | 0 | 852 | 985 | 825 | 883 |
| Total debt | 0 | 1 861 | 1 865 | 1 550 | 1 453 |
EBITDA margin
9.6%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
8.3%
This company
38.2%
Market median
-78% vs market
20202024
Return on equity
94.8%
This company
18.4%
Market median
+415% vs market
20202024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20202024
Asset turnover
2.16×
This company
1.12×
Market median
+93% vs market
20202024
Debt / equity
11.08×
This company
0.62×
Market median
-1687% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-10-23 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Almeland Holding As
ALMELAND HELSE AS Board members of ALMELAND HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miriam Sørheim Almeland | Chief Executive Officer | 0 companies |
| Stian Kreken Almeland | Chairman | 0 companies |